Cargando…
Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1
BACKGROUND: Increasing studies suggest that circular RNAs (circRNAs) are critical regulators of cancer development and progression. However, the biological roles and mechanisms of circRNAs in gastric cancer (GC) remain largely unknown. METHODS: We identified the differentially expressed circRNAs in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250212/ https://www.ncbi.nlm.nih.gov/pubmed/35780119 http://dx.doi.org/10.1186/s12943-022-01606-9 |
_version_ | 1784739761009721344 |
---|---|
author | Zang, Xueyan Jiang, Jiajia Gu, Jianmei Chen, Yanke Wang, Maoye Zhang, Yu Fu, Min Shi, Hui Cai, Hui Qian, Hui Xu, Wenrong Zhang, Xu |
author_facet | Zang, Xueyan Jiang, Jiajia Gu, Jianmei Chen, Yanke Wang, Maoye Zhang, Yu Fu, Min Shi, Hui Cai, Hui Qian, Hui Xu, Wenrong Zhang, Xu |
author_sort | Zang, Xueyan |
collection | PubMed |
description | BACKGROUND: Increasing studies suggest that circular RNAs (circRNAs) are critical regulators of cancer development and progression. However, the biological roles and mechanisms of circRNAs in gastric cancer (GC) remain largely unknown. METHODS: We identified the differentially expressed circRNAs in GC by analyzing Gene Expression Omnibus (GEO) datasets. We explored the biological roles of circRNAs in GC by in vitro functional assays and in vivo animal studies. We performed tagged RNA affinity purification (TRAP), RNA immunoprecipitation (RIP), mass spectrometry (MS), RNA sequencing, luciferase reporter assays, and rescue experiments to investigate the mechanism of circRNAs in GC. RESULTS: Downregulated expression of circular RNA EIF4G3 (circEIF4G3; hsa_circ_0007991) was found in GC and was associated with poor clinical outcomes. Overexpression of circEIF4G3 suppressed GC growth and metastasis through the inhibition of β-catenin signaling, whereas knockdown of circEIF4G3 showed the opposite effects. Mechanistic studies revealed that circEIF4G3 bound to δ-catenin protein to promote its TRIM25-mediated ubiquitin degradation and interacted with miR-4449 to upregulate SIK1 expression. CONCLUSION: Our findings uncovered a tumor suppressor function of circEIF4G3 in GC through the regulation of δ-catenin protein stability and miR-4449/SIK1 axis. CircEIF4G3 may act as a promising prognostic biomarker and therapeutic target for GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01606-9. |
format | Online Article Text |
id | pubmed-9250212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92502122022-07-03 Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 Zang, Xueyan Jiang, Jiajia Gu, Jianmei Chen, Yanke Wang, Maoye Zhang, Yu Fu, Min Shi, Hui Cai, Hui Qian, Hui Xu, Wenrong Zhang, Xu Mol Cancer Research BACKGROUND: Increasing studies suggest that circular RNAs (circRNAs) are critical regulators of cancer development and progression. However, the biological roles and mechanisms of circRNAs in gastric cancer (GC) remain largely unknown. METHODS: We identified the differentially expressed circRNAs in GC by analyzing Gene Expression Omnibus (GEO) datasets. We explored the biological roles of circRNAs in GC by in vitro functional assays and in vivo animal studies. We performed tagged RNA affinity purification (TRAP), RNA immunoprecipitation (RIP), mass spectrometry (MS), RNA sequencing, luciferase reporter assays, and rescue experiments to investigate the mechanism of circRNAs in GC. RESULTS: Downregulated expression of circular RNA EIF4G3 (circEIF4G3; hsa_circ_0007991) was found in GC and was associated with poor clinical outcomes. Overexpression of circEIF4G3 suppressed GC growth and metastasis through the inhibition of β-catenin signaling, whereas knockdown of circEIF4G3 showed the opposite effects. Mechanistic studies revealed that circEIF4G3 bound to δ-catenin protein to promote its TRIM25-mediated ubiquitin degradation and interacted with miR-4449 to upregulate SIK1 expression. CONCLUSION: Our findings uncovered a tumor suppressor function of circEIF4G3 in GC through the regulation of δ-catenin protein stability and miR-4449/SIK1 axis. CircEIF4G3 may act as a promising prognostic biomarker and therapeutic target for GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01606-9. BioMed Central 2022-07-02 /pmc/articles/PMC9250212/ /pubmed/35780119 http://dx.doi.org/10.1186/s12943-022-01606-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zang, Xueyan Jiang, Jiajia Gu, Jianmei Chen, Yanke Wang, Maoye Zhang, Yu Fu, Min Shi, Hui Cai, Hui Qian, Hui Xu, Wenrong Zhang, Xu Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title | Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title_full | Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title_fullStr | Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title_full_unstemmed | Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title_short | Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1 |
title_sort | circular rna eif4g3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating sik1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250212/ https://www.ncbi.nlm.nih.gov/pubmed/35780119 http://dx.doi.org/10.1186/s12943-022-01606-9 |
work_keys_str_mv | AT zangxueyan circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT jiangjiajia circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT gujianmei circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT chenyanke circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT wangmaoye circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT zhangyu circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT fumin circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT shihui circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT caihui circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT qianhui circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT xuwenrong circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 AT zhangxu circularrnaeif4g3suppressesgastriccancerprogressionthroughinhibitionofbcateninbypromotingdcateninubiquitindegradationandupregulatingsik1 |